Literature DB >> 29559361

Houston Consensus Conference on Testing for Helicobacter pylori Infection in the United States.

Hashem B El-Serag1, John Y Kao2, Fasiha Kanwal3, Mark Gilger4, Frank LoVecchio5, Steven F Moss6, Sheila E Crowe7, Adam Elfant8, Thomas Haas9, Ronald J Hapke10, David Y Graham11.   

Abstract

Despite guidelines for detection and treatment of Helicobacter pylori infection, recommendations to test patients before and after therapy are commonly not followed in the United States. At the Houston Consensus Conference, 11 experts on management of adult and pediatric patients with H pylori, from different geographic regions of the United States, met to discuss key factors in diagnosis of H pylori infection, including identification of appropriate patients for testing, effects of antibiotic susceptibility on testing and treatment, appropriate methods for confirmation of infection and eradication, and relevant health system considerations. The experts divided into groups that used a modified Delphi panel approach to assess appropriate patients for testing, testing for antibiotic susceptibility and treatment, and test methods and confirmation of eradication. The quality of evidence and strength of recommendations were evaluated using the GRADE system. The results of the individual workshops were presented for a final consensus vote by all panel members. After the Expert Consensus Development meeting, the conclusions were validated by a separate panel of gastroenterologists, who assessed their level of agreement with each of the 29 statements developed at the Expert Consensus Development. The final recommendations are provided, on the basis of the best available evidence, and provide consensus statements with supporting literature to implement testing for H pylori infection at health care systems across the United States.
Copyright © 2018 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bacterial Infection; Resistance; Stool Antigen Test; Urea Breath Test

Mesh:

Year:  2018        PMID: 29559361      PMCID: PMC6913173          DOI: 10.1016/j.cgh.2018.03.013

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  79 in total

Review 1.  The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia.

Authors:  Cindy Neunert; Wendy Lim; Mark Crowther; Alan Cohen; Lawrence Solberg; Mark A Crowther
Journal:  Blood       Date:  2011-02-16       Impact factor: 22.113

Review 2.  The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults.

Authors:  Carlo A Fallone; Naoki Chiba; Sander Veldhuyzen van Zanten; Lori Fischbach; Javier P Gisbert; Richard H Hunt; Nicola L Jones; Craig Render; Grigorios I Leontiadis; Paul Moayyedi; John K Marshall
Journal:  Gastroenterology       Date:  2016-04-19       Impact factor: 22.682

3.  GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations.

Authors:  Jeff Andrews; Gordon Guyatt; Andrew D Oxman; Phil Alderson; Philipp Dahm; Yngve Falck-Ytter; Mona Nasser; Joerg Meerpohl; Piet N Post; Regina Kunz; Jan Brozek; Gunn Vist; David Rind; Elie A Akl; Holger J Schünemann
Journal:  J Clin Epidemiol       Date:  2013-01-09       Impact factor: 6.437

4.  ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.

Authors:  William D Chey; Grigorios I Leontiadis; Colin W Howden; Steven F Moss
Journal:  Am J Gastroenterol       Date:  2017-01-10       Impact factor: 10.864

5.  Age at acquisition of Helicobacter pylori infection: a follow-up study from infancy to adulthood.

Authors:  Hoda M Malaty; Abdalla El-Kasabany; David Y Graham; Charles C Miller; Sidd G Reddy; Sathanur R Srinivasan; Yoshio Yamaoka; Gerald S Berenson
Journal:  Lancet       Date:  2002-03-16       Impact factor: 79.321

6.  Illusions regarding Helicobacter pylori clinical trials and treatment guidelines.

Authors:  David Y Graham
Journal:  Gut       Date:  2017-09-21       Impact factor: 23.059

Review 7.  Gastric lymphoma of mucosa-associated lymphoid tissue and Helicobacter pylori.

Authors:  A C Wotherspoon
Journal:  Annu Rev Med       Date:  1998       Impact factor: 13.739

Review 8.  Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users.

Authors:  M Vergara; M Catalán; J P Gisbert; X Calvet
Journal:  Aliment Pharmacol Ther       Date:  2005-06-15       Impact factor: 8.171

9.  The individual and joint contributions of Helicobacter pylori infection and family history to the risk for peptic ulcer disease.

Authors:  H Brenner; D Rothenbacher; G Bode; G Adler
Journal:  J Infect Dis       Date:  1998-04       Impact factor: 5.226

10.  Management of Helicobacter Pylori in the United States: Results from a national survey of gastroenterology physicians.

Authors:  Traci T Murakami; Rebecca A Scranton; Heidi E Brown; Robin B Harris; Zhao Chen; Sunitha Musuku; Eyal Oren
Journal:  Prev Med       Date:  2017-04-27       Impact factor: 4.018

View more
  53 in total

1.  Cancer mortality rates among US and foreign-born individuals: United States 2005-2014.

Authors:  Benjamin D Hallowell; Meheret Endeshaw; Matthew T McKenna; Virginia Senkomago; Hilda Razzaghi; Mona Saraiya
Journal:  Prev Med       Date:  2019-06-18       Impact factor: 4.018

2.  Oesophageal and proximal gastric adenocarcinomas are rare after detection of Helicobacter pylori infection.

Authors:  Shria Kumar; David C Metz; Gregory G Ginsberg; David E Kaplan; David S Goldberg
Journal:  Aliment Pharmacol Ther       Date:  2020-03-04       Impact factor: 8.171

Review 3.  Diagnosis: gastric intestinal metaplasia - what to do next?

Authors:  David Y Graham; Massimo Rugge; Robert M Genta
Journal:  Curr Opin Gastroenterol       Date:  2019-11       Impact factor: 3.287

4.  AGA Clinical Practice Guidelines on Management of Gastric Intestinal Metaplasia.

Authors:  Samir Gupta; Dan Li; Hashem B El Serag; Perica Davitkov; Osama Altayar; Shahnaz Sultan; Yngve Falck-Ytter; Reem A Mustafa
Journal:  Gastroenterology       Date:  2019-12-06       Impact factor: 22.682

5.  Reply.

Authors:  Hashem B El-Serag; David Y Graham
Journal:  Clin Gastroenterol Hepatol       Date:  2018-12       Impact factor: 11.382

6.  Reply.

Authors:  Hashem B El-Serag; David Y Graham
Journal:  Clin Gastroenterol Hepatol       Date:  2018-12       Impact factor: 11.382

7.  Is the Utilization of Helicobacter pylori Stool Antigen Tests Appropriate in an Urban Canadian Population?

Authors:  Irene Ma; Maggie Guo; Dylan R Pillai; Deirdre L Church; Christopher Naugler
Journal:  Am J Clin Pathol       Date:  2020-04-15       Impact factor: 2.493

8.  Risk Factors and Incidence of Gastric Cancer After Detection of Helicobacter pylori Infection: A Large Cohort Study.

Authors:  Shria Kumar; David C Metz; Susan Ellenberg; David E Kaplan; David S Goldberg
Journal:  Gastroenterology       Date:  2019-10-22       Impact factor: 22.682

9.  Prevalence of Gastric Intestinal Metaplasia in a Multiethnic US Veterans Population.

Authors:  Theresa H Nguyen; Mimi C Tan; Yan Liu; Massimo Rugge; Aaron P Thrift; Hashem B El-Serag
Journal:  Clin Gastroenterol Hepatol       Date:  2020-03-14       Impact factor: 11.382

10.  Resistance patterns of refractory H. pylori infection in a referral center in the Delaware Valley.

Authors:  Shria Kumar; Ravindra Sangitha; Irving Nachamkin; David C Metz
Journal:  GastroHep       Date:  2019-12-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.